ERD

ERDERA | EUROPEAN RARE DISEASES RESEARCH ALLIANCE

01-09-2024

-

31-08-2031

Show more information

Organisation FONDAZIONE TELETHON ETS

EJP RD | European Joint Programme on Rare Diseases

01-01-2019

-

31-08-2024

Show more information

Organisation FONDAZIONE TELETHON ETS

EP PerMed | European Partnership for Personalised Medicine

01-11-2023

-

31-10-2033

Show more information

Organisation FONDAZIONE TELETHON ETS

MENTOR | Metabolic control of cell growth by mTOR in health and disease: a multi-disciplinary training

01-01-2025

-

31-12-2028

Show more information

Organisation FONDAZIONE TELETHON ETS

INCIPIT | INnovative Life sCIence Phd Programme in South ITaly

01-01-2016

-

31-12-2021

Show more information

Organisation FONDAZIONE TELETHON ETS

ProgRet | European Training Program to Understand, Diagnose and Treat Autosomal Dominant Retinal Diseases

01-01-2024

-

31-12-2027

Show more information

Organisation FONDAZIONE TELETHON ETS

RETORNA | Targeting RNA as an approach for treating retinal disease

01-02-2023

-

31-01-2027

Show more information

Organisation FONDAZIONE TELETHON ETS

JOIN4ATMP | MAP, JOIN AND DRIVE EUROPEAN ACTIVITIES FOR ADVANCED THERAPY MEDICINAL PRODUCT DEVELOPMENT AND IMPLEMENTATION FOR PATIENT AND SOCIETY BENEFIT

01-01-2024

-

31-12-2026

Show more information

Organisation FONDAZIONE TELETHON ETS

Re-MEND | Building REsilience against MEntal illness during ENDocrine-sensitive life stages

01-01-2023

-

31-12-2027

Show more information

Organisation FONDAZIONE TELETHON ETS

LysoMod | Genetic and Small Molecule Modifiers of Lysosomal Function

01-03-2017

-

31-08-2022

Show more information

Organisation FONDAZIONE TELETHON ETS

StarT | European Training Network to Diagnose, Understand and Treat Stargardt Disease, a Frequent Inherited Blinding Disorder

01-10-2018

-

31-03-2023

Show more information

Organisation FONDAZIONE TELETHON ETS

IC2PerMed | Integrating China in the International Consortium for Personalised Medicine

01-01-2020

-

31-12-2023

Show more information

Organisation FONDAZIONE TELETHON ETS

IMMUTOL | ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED DISEASES

01-05-2023

-

30-04-2027

Show more information

Organisation FONDAZIONE TELETHON ETS

COSY-BIO | Control Engineering of Biological Systems for Reliable Synthetic Biology Applications

01-10-2017

-

31-03-2021

Show more information

Organisation FONDAZIONE TELETHON ETS

UshTher | Clinical trial of gene therapy with dual AAV vectors for retinitis pigmentosa in patients with Usher syndrome type IB

01-01-2018

-

30-06-2023

Show more information

Organisation FONDAZIONE TELETHON ETS

BATCure | Developing new therapies for Batten disease

01-01-2016

-

30-06-2019

Show more information

Organisation FONDAZIONE TELETHON ETS

RESTORE | RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients

01-03-2019

-

31-07-2020

Show more information

Organisation FONDAZIONE TELETHON ETS

UPGRADE | Unlocking Precision Gene Therapy

01-01-2019

-

30-06-2024

Show more information

Organisation FONDAZIONE TELETHON ETS

AAVolution | Next-generation AAV vectors for liver-directed gene therapy

01-10-2022

-

30-09-2026

Show more information

Organisation FONDAZIONE TELETHON ETS

X-PAND | Exploiting ex vivo expansion and deep multiomics profiling to bring novel, efficient and safer hematopoietic stem cell gene therapies to clinical application

01-10-2022

-

30-09-2026

Show more information

Organisation FONDAZIONE TELETHON ETS

AUTO-SELECT | Dissect cargo selectivity in autophagy

01-01-2023

-

31-12-2027

Show more information

Organisation FONDAZIONE TELETHON ETS

LYSOCIL | Excel in Rare Diseases’ Research: Focus on LYSOsomal Disorders and CILiopathies

01-11-2018

-

30-04-2022

Show more information

Organisation FONDAZIONE TELETHON ETS

EYEGET | Gene therapy of inherited retinal diseases

01-01-2017

-

31-12-2022

Show more information

Organisation FONDAZIONE TELETHON ETS

inSight | Moving a novel gene therapy paradigm to treat blindness to the market

01-06-2019

-

31-05-2021

Show more information

Organisation FONDAZIONE TELETHON ETS

EXPEDITE | EXPanding AAV gene therapy by EDITing

01-11-2023

-

31-10-2028

Show more information

Organisation FONDAZIONE TELETHON ETS

INCANTAR | TARGETING INHERITED CANCER SYNDROMES

01-09-2023

-

31-08-2028

Show more information

Organisation FONDAZIONE TELETHON ETS

RE-STORE | Pharmacological restoration of selective autophagy for the treatment of skeletal disorders

01-01-2021

-

30-06-2022

Show more information

Organisation FONDAZIONE TELETHON ETS

EASY-IPS | a rapid and efficient method for generation of iPSC

01-01-2019

-

28-02-2021

Show more information

Organisation FONDAZIONE TELETHON ETS

BONEPHAGY | Defining the role of the FGF – autophagy axis in bone physiology

01-01-2017

-

31-12-2022

Show more information

Organisation FONDAZIONE TELETHON ETS

GeneVision | Developing a cure for retinitis pigmentosa due to Usher syndrome

01-04-2017

-

30-09-2018

Show more information

Organisation FONDAZIONE TELETHON ETS

Projects overview

Selected filters:

ERDERA | EUROPEAN RARE DISEASES RESEARCH ALLIANCE

EJP RD | European Joint Programme on Rare Diseases

EP PerMed | European Partnership for Personalised Medicine

MENTOR | Metabolic control of cell growth by mTOR in health and disease: a multi-disciplinary training

INCIPIT | INnovative Life sCIence Phd Programme in South ITaly

ProgRet | European Training Program to Understand, Diagnose and Treat Autosomal Dominant Retinal Diseases

RETORNA | Targeting RNA as an approach for treating retinal disease

JOIN4ATMP | MAP, JOIN AND DRIVE EUROPEAN ACTIVITIES FOR ADVANCED THERAPY MEDICINAL PRODUCT DEVELOPMENT AND IMPLEMENTATION FOR PATIENT AND SOCIETY BENEFIT

Re-MEND | Building REsilience against MEntal illness during ENDocrine-sensitive life stages

LysoMod | Genetic and Small Molecule Modifiers of Lysosomal Function

StarT | European Training Network to Diagnose, Understand and Treat Stargardt Disease, a Frequent Inherited Blinding Disorder

IC2PerMed | Integrating China in the International Consortium for Personalised Medicine

IMMUTOL | ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED DISEASES

COSY-BIO | Control Engineering of Biological Systems for Reliable Synthetic Biology Applications

UshTher | Clinical trial of gene therapy with dual AAV vectors for retinitis pigmentosa in patients with Usher syndrome type IB

BATCure | Developing new therapies for Batten disease

RESTORE | RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients

UPGRADE | Unlocking Precision Gene Therapy

AAVolution | Next-generation AAV vectors for liver-directed gene therapy

X-PAND | Exploiting ex vivo expansion and deep multiomics profiling to bring novel, efficient and safer hematopoietic stem cell gene therapies to clinical application

AUTO-SELECT | Dissect cargo selectivity in autophagy

LYSOCIL | Excel in Rare Diseases’ Research: Focus on LYSOsomal Disorders and CILiopathies

EYEGET | Gene therapy of inherited retinal diseases

inSight | Moving a novel gene therapy paradigm to treat blindness to the market

EXPEDITE | EXPanding AAV gene therapy by EDITing

INCANTAR | TARGETING INHERITED CANCER SYNDROMES

RE-STORE | Pharmacological restoration of selective autophagy for the treatment of skeletal disorders

EASY-IPS | a rapid and efficient method for generation of iPSC

BONEPHAGY | Defining the role of the FGF – autophagy axis in bone physiology

GeneVision | Developing a cure for retinitis pigmentosa due to Usher syndrome